This page contains a Flash digital edition of a book.
PROMOTION


An innovative approach to obtaining harmonious and balanced facial rejuvenation


HYDROLIFT ACTION:


Annalisa Beatini discusses her experience using HYDROLIFT™ ACTION with the objective of restoring hydration (HYDRO), volume (LIFT) and turgor, combining cross-linked hyaluronic acid and natural hyaluronic acid, while ensuring safety and efficacy


I


DR ANNALISA BEATINI currently practices Aesthetic Medicine, Dermatologic Surgery and Laser Therapy, Liguria, Italy


N THE PROCESS OF CUTANEOUS AGEING, the effects of cronoageing and photoageing manifest differently. The gravitational pull on facial skin, structural bone changes, reabsorption of adipose tissue, and loss of turgor and elasticity owing to elastic fibre and collagen reduction and damage, are some of the problems we work to resolve on a daily basis. In fact, there are a number of methods that may be


used to reverse the effects of ageing, from surgery to laser treatments, to deep peels, but the request received from the majority of patients is for a treatment that is safe, pain-free, with no down-time, and showing immediate results, without complications. Hyaluronic acid (HA), a molecule


naturally present in our skin, has enabled us to respond to these demands; and over time, not only has HA been formulated into different concentrations and cross-linking grades to personalise treatments for the wide variety of imperfections, but at the same time the number of implant methods have multiplied also. One of the most recent methods implements the use of a cannula, which allows the treatment of the entire face with only four entrance points, using the products most suitable for obtaining the desired results, from restoring facial volume to improving skin texture, radiance, turgor and elasticity. Generally, these results are obtained through a number of treatments involving the scheduling of different aesthetic treatments, which often compromise patient compliance owing to repeated invasiveness of the entire therapeutic process. Furthermore, the use of HA at an elevated viscosity


56 ❚


and cross-linking grade sometimes causes — especially in very thin skin — the appearance of lines similar to a


September 2012 | prime-journal.com


‘pipe organ’ where the material has been implanted. This effect is most evident from the entrance point in the zygomatic region to the pre-tragus region, and disappears towards the malar region, where the skin is thicker.


“Using the methods


described by the author, the


result achieved in both groups was a uniform distribution of the product without the negative


aesthetic ‘pipe organ’ effect.





Aims The objective of the author is to improve and expand the practice of this therapeutic rationale. The concept of HYDROLIFT™ ACTION proposes a simple, effective approach for obtaining this goal. The author has chosen to combine ALIAXIN® SR, an intradermal product pre-formulated with a combination of natural and cross-linked HA, with VISCODERM®, a natural HA for biorestructuration, or VISCODERM® SKINKO’, a natural HA combined with an anti-ageing


complex


for biocomplementation, in order to achieve the optimum results. The rationale behind this method is to


regulate the density of the injectable solution in order to obtain a desired lifting effect, and at the same time reach the objective of improving the cutaneous texture through biorestructuration or biocomplementation depending on the level of ageing of the patient. Therefore, the solution obtained by this combination becomes much easier to inject and distribute, and consequently,


the aesthetic results are more natural and homogeneous.


Materials and methods ■ALIAXIN® SR, monophasic gel formulated with three


different molecular weights (500 kDA, 1000 kDA, 2000 kDA), containing 22.5 mg/ml of cross-linked NAHA and 2.5 mg/ml natural NAHA (0.1 ppm BDDE)


■VISCODERM® 2.0%, 20 mg/ml NAHA ■VISCODERM® SKINKO’ injectable solution in 5 ml


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84